S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, FOLLOWED BY K MAINTENANCE OR OBSERVATION IN TRANSPLANT NON-ELIGIBLE PATIENTS WITH NDMM (AGMT-MM02 TRIAL)

• H. Ludwig,
• T. Melchardt,
• S. Sormann,
• N. Zojer,
• J. Andel,
• B. Hartmann,
• C. Tinchon,
• E. Gunsilius,
• K. Podar,
• A. Egle,
• W. Willenbacher,
• E. Wöll,
• M. Schreder,
• R. Ruckser,
• B Bozic,
• M.-T. Krauth,
• A. Petzer,
• C Schmitt,
• S. Machherndl-Spandl,
• H. Agis,
• M. Fillitz,
• W. Pönisch,
• S. Knop,
• B. Paiva,
• R. Greil

Affiliations

H. Ludwig

1 Wilhelminen Cancer Research Institute, Vienna

T. Melchardt

2 Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute – Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsius Medical University, Cancer Cluster Salzburg, Salzburg

S. Sormann

3 Department of Internal Medicine, University Clinic Graz, Graz

N. Zojer

4 Department of Medicine I, Clinic Ottakring, Vienna

J. Andel

5 Department of Internal Medicine IIr, Pyhrn-Eisenwurzen Klinikum Steyr, Steyr

B. Hartmann

6 Department of Internal Medicine II, LKH Rankweil, Rankweil

C. Tinchon

7 Department of Internal Medicine, LKH Hochsteiermark, Leoben

E. Gunsilius

8 Department of Internal Medicine V, Medical University Innsbruck, Innsbruck

K. Podar

9 Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems

A. Egle

2 Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute – Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsius Medical University, Cancer Cluster Salzburg, Salzburg

W. Willenbacher

8 Department of Internal Medicine V, Medical University Innsbruck, Innsbruck

E. Wöll

11 Department of Internal Medicine, KH Zams, Zams

M. Schreder

4 Department of Medicine I, Clinic Ottakring, Vienna

R. Ruckser

12 Department of Medicine II, Clinic Donaustadt

B Bozic

12 Department of Medicine II, Clinic Donaustadt

M.-T. Krauth

13 Department of Internal Medicine I, Division Hematology & Hemostaseology, Medical University Vienna, Vienna

A. Petzer

14 Department of Internal Medicine I, Ordensklinikum Linz Barmherzige Schwestern

C Schmitt

15 Clinic for Internal Medicine

S. Machherndl-Spandl

16 Ordensklinikum Linz Elisabethinen, Linz

H. Agis

17 Department of Internal Medicine I, Division of Oncology, Medical University Vienna

M. Fillitz

18 Department of Internal Medicine, Hanusch Krankenhaus, Vienna, Austria

W. Pönisch

19 Medical Clinic and Policlinic I, University Clinic Leipzig, Leipzig

S. Knop

20 Medical Clinic and Policlinic II, University Clinic Würzburg, Würzburg, Germany

B. Paiva

21 Clinica Universidad de Navarra, Pamplona, Spain

R. Greil

2 Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute – Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsius Medical University, Cancer Cluster Salzburg, Salzburg